These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 2916237
1. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Nemali MR, Reddy MK, Usuda N, Reddy PG, Comeau LD, Rao MS, Reddy JK. Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237 [Abstract] [Full Text] [Related]
2. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Cancer Res; 1988 Sep 15; 48(18):5316-24. PubMed ID: 2900680 [Abstract] [Full Text] [Related]
3. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Yeldandi AV, Rao MS, Reddy JK. Mutat Res; 2000 Mar 17; 448(2):159-77. PubMed ID: 10725470 [Abstract] [Full Text] [Related]
5. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Lalwani ND, Reddy MK, Qureshi SA, Sirtori CR, Abiko Y, Reddy JK. Hum Toxicol; 1983 Jan 17; 2(1):27-48. PubMed ID: 6840792 [Abstract] [Full Text] [Related]
6. Xenobiotic-induced peroxisome proliferation: role of tissue specificity and species differences in response in the evaluation of the implications for human health. Reddy JK, Rao MS. Arch Toxicol Suppl; 1987 Jan 17; 10():43-53. PubMed ID: 3555419 [Abstract] [Full Text] [Related]
9. Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease. Youssef J, Badr M. Crit Rev Toxicol; 1998 Jan 17; 28(1):1-33. PubMed ID: 9493760 [Abstract] [Full Text] [Related]
11. Changes in peroxisomes and mitochondria in liver of ethionine exposed rats: a biochemical and morphological investigation. Aarsaether N, Aarsland A, Kryvi H, Nilsson A, Svardal A, Ueland PM, Berge RK. Carcinogenesis; 1989 Jun 17; 10(6):987-94. PubMed ID: 2498002 [Abstract] [Full Text] [Related]
13. PPAR: a mediator of peroxisome proliferator action. Green S. Mutat Res; 1995 Dec 17; 333(1-2):101-9. PubMed ID: 8538617 [Abstract] [Full Text] [Related]
17. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Reddy JK, Reddy MK, Usman MI, Lalwani ND, Rao MS. Environ Health Perspect; 1986 Mar 17; 65():317-27. PubMed ID: 3709457 [Abstract] [Full Text] [Related]
18. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Tamura H, Iida T, Watanabe T, Suga T. Carcinogenesis; 1990 Mar 17; 11(3):445-50. PubMed ID: 2311188 [Abstract] [Full Text] [Related]
19. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Rose ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG. Chem Res Toxicol; 1997 Oct 17; 10(10):1198-204. PubMed ID: 9348444 [Abstract] [Full Text] [Related]
20. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS, Cattley RC, Conway JG, Popp JA. Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]